T 1730/16 (Risedronate dosage regime/ALLERGAN) of 28.10.2020
- European Case Law Identifier
- ECLI:EP:BA:2020:T173016.20201028
- Date of decision
- 28 October 2020
- Case number
- T 1730/16
- Petition for review of
- -
- Application number
- 02795891.7
- IPC class
- A61P 19/10A61K 31/663
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- METHOD FOR THE TREATMENT OF BONE DISORDERS
- Applicant name
- Allergan Pharmaceuticals International Limited
- Opponent name
- -
- Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56 (2007)European Patent Convention R 103 (2014)
- Keywords
- Inventive step - (no)
Reimbursement of appeal fee at 25%
Reimbursement of appeal fee - withdrawal of the request for oral proceedings - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The appeal is dismissed.
2. The appeal fee is reimbursed at 25%.